Background: Nasal polyposis is characterised by persistent inflammation of the upper airways. Autophagy has been implicated in many chronic inflammatory diseases. Whether autophagy plays a role in nasal polyp (NP) inflammation is completely unknown and deserves investigation.
Introduction
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous upper airway disease histologically characterised by extensive oedema and increased inflammatory cell infiltration (1) . Microorganisms have been thought to contribute to the aetiology and pathophysiology of CRSwNP. However, the initiating event that triggers NP formation remains unidentified. Still, it is generally believed that abnormal and persistent host inflammation, in response to the exogenous stimuli such as microorganisms, plays a central role in the pathogenesis of CRSwNP. Supporting this are the findings that NP is typically distinguished by Th2-skewed eosinophilic inflammation with high IL-5 and eosinophil cationic protein (ECP) levels (2) (3) (4) , albeit the variation in this inflammatory profile among different ethnic entities (5) .
Cyclooxygenase-2 (COX-2) is the key enzyme that catalyzes the conversion of arachidonic acid to prostanoids, resulting in the production of prostaglandin and thromboxane mediators. Such lipid mediators are important for the generation of inflammatory response, for which COX-2 has become the target of non-steroidal anti-inflammatory drugs (NSAIDs). COX-2 is not detectable in most normal tissues but is promptly induced in response to inflammatory stimuli, leading to increased accumulation of prostanoids in inflamed tissues (6) . In cultured human NP explants, it was reported that COX-2 mRNA was spontaneously upregulated or induced by pro-inflammatory cytokines (7, 8) . Likewise, a significant basal level of COX-2 mRNA was observed in NP fibroblasts, which could be further induced by inflammatory mediators (9) . Moreover, there is strong protein expression of COX-2 in chronically inflamed nasal mucosa (10) . A recent report indicated that COX-2 mRNA was upregulated in NP in patients with cystic fibrosis (11) . Therefore, COX-2 might have an impact on NP pathogenesis.
Autophagy is a cellular catabolic process that delivers cytosolic proteins and organelles to lysosomal degradation and recycling, which is necessary for diverse physiological functions such as survival, differentiation, development and homeostasis (12) . However, little is known about the role of autophagy in the disease mechanism of CRSwNP. We have previously shown that autophagy is significantly deficient in NP tissues and NP-derived fibroblasts presumably due to the activation of the Akt-mTOR signaling pathway (in press). In this study, we further demonstrated that the reduction of autophagy might lead to enhanced COX-2 expression in NP tissues and NP-derived fibroblasts, suggesting a possible mechanistic link between autophagy and inflammation in NP pathogenesis.
Materials and methods

Materials and plasmid
Dulbecco's Modified Eagle's Medium (DMEM) and Hank's Balanced Salt Solution (HBSS) were from Invitrogen (Carlsbad, CA, USA). Anti-microtubule-associated protein light chain 3 (LC3) antibody (LC3B, clone D11) was purchased from Cell Signaling (Danvers, MA, USA), and anti-COX-2 and anti-GAPDH were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). IL-1β, TNF-α and 3-Methyladenine (3-MA) were obtained from Sigma. A GFP-LC3 construct was kindly provided by Dr. W.-B. Huang of National Taiwan University, Taiwan.
Patients and tissues
The study was approved by the Institutional Review Board (IRB) of Kaohsiung Medical University Hospital. Based on the definition in the European position paper on rhinosinusitis and nasal polyps (13) , patients with latest diagnosis of CRSwNP undergoing elective endoscopic sinus surgery at our hospital were recruited.
Patients with malignancies or asthma were excluded from the study. The recruited patients did not use intranasal steroid spray nor did they take other systemic medication at least two weeks before operation. Nasal polyp tissues (NP, n = 28; 5 for Western blot and 23 for immunohistochemistry) were obtained from patients with CRSwNP. Control nasal mucosa (NM, n = 6 for Western blot) was isolated from the bulla ethmoid in patients with chronic rhinosinusitis without nasal polyps (CRSsNP).
Tissue lysates and Western blot analysis
Each nasal tissue sample was washed twice with PBS and then immersed in 500 μl T-PER® Tissue Protein Extraction Reagent (Thermo Scientific) with 1% protease inhibitor cocktail and 1% phosphatase inhibitor cocktail. The tissues were homogenized with a handheld Bio-Gen PRO200 homogenizer (PRO Scientific) on ice for 1 min. Tissue lysates were collected after centrifugation at 13,000 rpm at 4°C for 30 min. Detailed procedures for Western blot analysis were previously described (14) . Briefly, tissue lysates (60 μg) from each sample were separated on SDS-PAGE and transferred to PVDF membrane. After blocking, the blots were incubated with antibodies against LC3, COX-2 and GAPDH. GAPDH was used as the loading control. Quantification of the data was performed by densitometry.
Primary culture of nasal fibroblasts
Nasal tissues were washed three times with antibiotics- 
Statistical analysis
Expression of LC3 and COX-2 in fresh nasal tissues was analysed by Student's t-test. The staining intensity of LC3 and COX-2 in NP tissue sections was analysed by Fisher's exact test. The correlation between LC3 and COX-2 expression in NP sections was further evaluated by kappa statistic (JMP 9.0, SAS Institute, Cary, NC, USA). Probability value below 0.05 (p < 0.05) was considered statistically significant.
Results
High COX-2 but low LC3 expression in fresh NP tissues
Fresh tissues of six control nasal mucosa (NM) and five nasal polyps (NP) were obtained from patients with CRSsNP and CRSwNP, respectively. Tissues lysates were isolated and then subjected to Western blot analysis for detection of the autophagy marker LC3 and inflammation marker COX-2. As shown in Figure 1 , LC3 expression was much higher in NM than that in NP samples (p < 0.01). In sharp contrast, COX-2 expression was significantly increased in all five NP samples compared to that in the NM control (p < 0.001). These results indicated that autophagy was suppressed while COX-2 expression was induced in NP tissues.
Autophagic activity affects COX-2 expression in NP-derived fibroblasts
We established primary cultures of NM-and NP-derived fibroblasts (NMDFs and NPDFs) to demonstrate whether COX-2 expression was regulated by autophagy. COX-2 expression was These results might also rule out the possibility that inflammation exerted a negative feedback effect on autophagy.
Negative correlation between autophagy and inflammation in NP tissues by immunohistochemistry
To support the results that COX-2 expression was negatively regulated by autophagy in NP, we investigated the correlation between the expression of COX-2 and LC3 in tissue sections from 23 NP patients by immunohistochemistry. We found that the vast majority of NP tissues (17/23) had negative to weak LC3 staining intensity, while more than 50% of the NP tissues (12/23) had moderate to strong COX-2 staining intensity (p < 0.05 by Fisher's exact test) (Table 1) . Moreover, COX-2 immunostaining was localized primarily to the epithelium and moderately to the submucosal area in the NP specimens (Figure 4 ). Kappa statistic further demonstrated an inverse relationship between LC3 and COX-2 expression (κ = -0.363, p = 0.043) ( Table 2 ). As shown in Figure 4 , three representative cases of two consecutive NP sections stained respectively with anti-LC3 and anti-COX-2 antibodies revealed high COX-2 (moderate to strong) but low (or negative) LC3 expression in the same area of the tissues.
Discussion
Nasal polyps (NP) remains one of the most challenging and refractory diseases in clinical rhinology because of its hetero- geneous aetiology and pathophysiology and predisposition to recurrence. It occurs in about 4% of the general population, whose quality of life is seriously disturbed by the disease (15) .
Unfortunately, the precise mechanism underlying the pathogenesis of NP has not been unraveled. There is an emerging consensus that persistent inflammation resulting from dysfunctional host immune response to exogenous agents contributes significantly to NP formation (16) .
Autophagy is a cellular catabolic process whereby the unwanted proteins and organelles are degraded and it has been associated with many human inflammatory diseases (17) (18) (19) (20) . We had previously demonstrated that autophagy was suppressed in NP tissues and NP-derived fibroblasts (NPDFs) possibly due to high Akt-mTOR activity (in press). To further explore the biological function of autophagy in NP pathogenesis, we investigated the correlation between autophagy and inflammation. We found that a deficiency of autophagy was accompanied with drastically increased levels of COX-2, the widely accepted inflammation indicator, in NP tissues. In contrast, most of the control nasal mucosa (NM) had high LC3, the autophagy marker, but low COX-2 expression level. These results propelled us to hypothesize that inflammation was regulated by autophagy or vice versa in NP. The hypothesis was tested by in vitro studies.
We used nasal fibroblasts as the cell model because they are the ground substances in submucosa of NP and mediate many 
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Negative immunological responses. In addition, COX-2 was shown to be expressed in fibroblasts located in the submucosal region of NP tissues ( Figure 4 ). By manipulating autophagic activity in this cell model, we found that COX-2 expression was decreased when autophagy was induced by amino acid starvation or LC3 ectopic overexpression. Furthermore, using the reverse approach, our data showed that COX-2 expression was increased when autophagy was attenuated by the inhibitor 3-MA in the fibroblasts.
It is notable that COX-2 expression was elevated more dramatically in NPDFs than that in NMDFs despite comparable extent of LC3 reduction in the cells. This might indicate that COX-2 was more specifically, albeit negatively, regulated by autophagy in NPDFs, consistent with the tissue results shown in Figure 1 . Collectively, these results suggest that inflammation is negatively regulated by autophagy in NP, which is in line with the growing recognition that autophagy has an anti-inflammatory function that suppresses inflammasome activation (21) (22) (23) . However, the mechanism by which autophagy inhibits COX-2 expression in NP is not clear. We noticed a rapid decrease of COX-2 expression in as little as 3 h after autophagy induction (Figure 2A ), suggesting a more likely scenario in which such repression occurred at the posttranscriptional level. There is evidence that COX-2 expres-sion was inhibited through modulation of its mRNA stability in cancer cells (24, 25) . Whether autophagy regulates COX-2 expression by this mechanism in NP has yet to be demonstrated.
Our findings showed that COX-2 expression was negatively regulated by autophagy in NPDFs. Intriguingly, there are reports that IL-1 receptor blockade by the antagonist restores autophagy in chronic granulomatous disease (CGD) (18) and celecoxib, a COX-2 inhibitor, induces LC3 expression in urothelial carcinoma cells (26) , indicating that inflammation might negatively regulate autophagy in certain cell contexts. Still, it remains unknown why autophagy is deficient in NP. It has been shown that mutations in the autophagy-associated gene ATG16L1 (T300A mutation) resulted in defective autophagy activity and contributed to susceptibility to Crohn's disease (27, 28) . Given our previous results that the Akt-mTOR signaling pathway is highly activated in NP tissues, it becomes less likely that the autophagy deficiency in NP was due to genetic variations. On the other hand, several lines of evidence have reported that, cystic fibrosis (CF), a chronic inflammatory airway disease, is autophagy deficient (29) (30) (31) . In these studies, a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) results in autophagy deficiency because of functional sequestration of BECN1, an essential regulator for autophagosome formation, through a ROS-mediated mechanism. However, it remains to be elucidated whether it is high ROS levels that promote Akt-mTOR activity, in turn leading to inhibition of autophagy in NP.
Conclusions
In conclusion, we have demonstrated that autophagy could be involved in the mechanism of inflammation in NP. Our data indicate that autophagy is not only deficient but negatively correlated with COX-2 expression in NP. By an in vitro model, COX-2 was shown to be negatively regulated by autophagy in both NMDFs and NPDFs, raising the possibility that chronic mucosal inflammation in NP resulted from persistent deficiency of autophagy.
Whether attenuating or modulating inflammation by restoring autophagy could be a plausible therapeutic strategy for NP warrants further investigation.
